Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2011 Sep;140(3):781-788.
doi: 10.1378/chest.10-2068.

Aerosol therapy for obstructive lung diseases: device selection and practice management issues

Michael W Sims  1
Affiliations
Review

Aerosol therapy for obstructive lung diseases: device selection and practice management issues

Michael W Sims. Chest. 2011 Sep.

Abstract

Inhaled aerosol therapies are the mainstay of treatment of obstructive lung diseases. Aerosol devices deliver drugs rapidly and directly into the airways, allowing high local drug concentrations while limiting systemic toxicity. While numerous clinical trials, literature reviews, and expert panel guidelines inform the choice of inhalational drugs, deciding which aerosol device (ie, metered-dose inhaler, nebulizer, or dry powder inhaler) best suits a given patient and clinical setting can seem arbitrary and confusing. Similar confusion regarding Current Procedural Terminology (CPT) coding for administration of aerosol therapies can lead to lost revenue from underbilling and wasted administrative effort handling denied claims. This article reviews the aerosol devices currently available, discusses their relative merits in various clinical settings, and summarizes appropriate CPT coding for aerosol therapy.

PubMed Disclaimer

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Global strategy for diagnosis, management, and prevention of COPD Global Initiative for Chronic Obstructive Lung Disease Web site. http://www.goldcopd.org. Updated 2010. Accessed August 11, 2010.
    1. Global strategy for asthma management and prevention Global Initiative for Asthma Web site. http://www.ginasthma.org. Updated 2009. Accessed August 11, 2010.
    1. Flume PA, O’Sullivan BP, Robinson KA, et al. Cystic Fibrosis Foundation, Pulmonary Therapies Committee Cystic fibrosis pulmonary guidelines: chronic medications for maintenance of lung health. Am J Respir Crit Care Med. 2007;176(10):957–969. - PubMed
    1. Pasteur MC, Bilton D, Hill AT, British Thoracic Society Bronchiectasis non-CF Guideline Group British Thoracic Society guideline for non-CF bronchiectasis. Thorax. 2010;65(suppl 1):i1–i58. - PubMed
    1. Dolovich MB, Ahrens RC, Hess DR, et al. American College of Chest Physicians American College of Asthma, Allergy, and Immunology Device selection and outcomes of aerosol therapy: Evidence-based guidelines: American College of Chest Physicians/American College of Asthma, Allergy, and Immunology. Chest. 2005;127(1):335–371. - PubMed

Publication types

Substances